Hepatology Digest: What is your opinion of non - invasive diagnosis of cirrhosis non - invasiveinvasive?
《国际肝病》: 您对于肝硬化以及它的并发症的 非 侵入性诊断有何看法?
互联网
Hepatology Digest: What are the criteria for a definitive diagnosis of PBC?
国际肝病: PBC的权威性诊断标准是什么?
互联网
Hepatology Digest: What would be your experience and approach Professor Xie?
《国际肝病》: 谢教授您的经验 呢 ?
互联网
Hepatology Digest: The nuclear receptors are important in cholestatic liver disease.
国际肝病: 核受体在胆汁淤积性肝病很重要.
互联网
Hepatology Digest nuclear receptors are important in cholestatic liver disease.
国际肝病:胆汁淤积性肝病是一种罕见的慢性肝病.
互联网
Hepatology Digest: For nucleotide analogues, drug resistance is an inevitable problem.
《国际肝病》: 对于核苷(酸)类似物来说, 出现耐药是不可避免的问题.
互联网
Hepatology Digest: What will you pay attention to during molecular target therapy?
《国际肝病》:分 子靶向治疗时需要注意什么问题?
互联网
Hepatology Digest: Liver biopsy is an invasive test.
《国际肝病》: 肝活检是一种有创检查.
互联网
Hepatology Digest: Please give us a brief introduction of the study of ubiquitination of liver disease.
《国际肝病》: 请简单介绍一下肝脏疾病中泛素化研究的进展.
互联网
Lindsay KL . Introduction to therapy and hepatitis C . Hepatology, 2002 , 36 ( Suppl ) : S 114 - 120 , S 121 - 127 , S 135 - 144.
姚光弼. 正确认识和评价拉米夫定在治疗慢性乙型肝炎中的地位. 肝脏, 2002, 7:73-74.
互联网
Hepatology Digest: Do you think HCC is a major indication for living donor liver transplantation ? Why?
《国际肝病》: 您认为肝细胞癌是活体供肝肝移植的重要适应证 吗,为什么?
互联网
Hepatology Digest: You mentioned on the treatment side, how about on the imaging side of diagnostics.
国际肝病: 您提到了治疗方面, 关于诊断方面又怎样呢?
互联网
Hepatology Digest: This year you conducted a prospective population - based surveillance to estimate newly diagnosed CLD incidence.
《国际肝病》: 您今年开展了一项基于人群的前瞻性监测研究,以评估新近诊断的慢性肝病患病率.
互联网
Hepatology Digest: Ascites in patients with liver cirrhosis is often accompanied by spontaneous bacterial peritonitis.
《国际肝病》: 合并腹水的肝硬化患者经常伴发自发性细菌性腹膜炎.
互联网
Hepatology Digest: The use of stem cells has been as a potential alternative for liver transplantation.
《国际肝病》: 干细胞目前已经被视为肝移植潜在的替代选择.
互联网